期刊文献+

PVB和TP方案对局部晚期宫颈癌患者的治疗效果及预后的比较 被引量:6

Efficacy and Prognosis of PVB and TP Chemotherapy for Locally Advanced Cervical Cancer
下载PDF
导出
摘要 目的探讨局部晚期宫颈癌患者经过PVB和TP化疗方式治疗的效果和预后的情况。方法收集128例局部晚期宫颈癌患者的临床相关资料,其中68例进行TP方案化疗(顺铂+紫杉醇),另外60例进行PVB方案化疗(顺铂+长春新碱+博莱霉素),化疗后进行手术。统计2组患者的近期疗效、术后病理情况以及不良反应发生情况。结果在TP组中,鳞癌患者的治疗有效率为85.0%,非鳞癌患者的治疗有效率为76.9%;而在PVB组中,鳞癌患者的治疗有效率为72.2%,非鳞癌患者的治疗有效率为45.8%。TP组非鳞癌患者的有效率显著高于PVB组非鳞癌患者,差异有统计学意义(P<0.05)。在淋巴结、脉管转移发生率和宫旁切缘、阴道切缘阳性率方面,PVB组和TP组无统计学差异(P>0.05)。在血液系统不良反应方面,红细胞减少和血小板减少发生情况2组不存在统计学差异(P>0.05),TP组患者的骨髓抑制发生率显著低于PVB组患者(P<0.05);在非血液系统不良反应方面,放射性损伤、胃肠道反应、周围神经毒性和肝肾功能损害发生情况2组均不存在统计学差异(P>0.05)。结论局部晚期宫颈癌患者术前进行TP方案化疗的近期疗效优于PVB方案,特别是非鳞癌患者。在改善预后方面两种方案一致,但TP方案毒副作用高于PVB方案。 Objective To study the efficacy and prognosis of PVB and TP chemotherapy for locally advanced cervical cancer. Methods Clinical data of 128 cases of patients with locally advanced cervical cancer were collected, including 68 patients with TP chemotherapy( cisplatin plus paclitaxel) ,60 patients were treated with PVB scheme chemotherapy( cisplatin + vincristine + lai toxin), surgery after chemotherapy. Statistics of the recent efficacy of the 2 groups, postoperative pathological conditions as well as the occurrence of adverse reaction. Results In the TP group,the treatment of patients with squamous carcinoma of the effective rate was 85.0% ,not the treatment of patients with squamous carcinoma of the effective rate was 76.9% ;In the PVB group,the treatment of patients with squamous carcinoma of the effective rate was 72.2%, the treatment of patients with squamous carcinoma of the effective rate was 45.8%. Efficiency of TP group was significantly higher than PVB group, the difference was statistically significant(P 〈 0.05 ). In the lymph nodes, the incidence of vascular metastasis and palace next to the cutting edge, vaginal cut edge positive aspects, PVB and TP groups there was no significant difference ( P 〉 0.05 ) ; In the aspect of adverse reaction of the blood, red blood cells to reduce and thrombocytopenia occurring situation of the 2 groups of patients, there was no significant difference(P 〉0.05 ), TP group had a significantly higher incidence of bone marrow suppression in patients with PVB group of patients ( P 〈 0.05 ) ; In the aspect of adverse reaction of the blood, radiation damage, gastrointestinal reaction and peripheral nerve toxicity and function of liver and kidney damage was happening, there was no significant difference in both groups(P 〉 0. 05 ). Conclusion For patients with locally advanced cervical cancer on preoperative TP plan of chemotherapy short-term curative effect is superior to the PVB, especially not squamous carcinoma patients,the 2 kinds of
出处 《实用癌症杂志》 2017年第5期808-810,816,共4页 The Practical Journal of Cancer
关键词 局部晚期宫颈癌 TP方案 PVB方案 化疗方式 Locally advanced cervical cancer TP plan PVB plan Chemotherapy way
  • 相关文献

参考文献9

二级参考文献86

  • 1管忠震,徐瑞华.奈达铂临床研究进展[J].中国肿瘤临床,2004,31(13):774-780. 被引量:176
  • 2王平,彭芝兰,张家文,刘辉,张崇淑,曹泽毅.子宫颈癌新辅助化疗中不同化疗途径的疗效比较[J].中华妇产科杂志,2005,40(4):227-230. 被引量:109
  • 3程晓东,吕卫国,叶枫,陈怀增,谢幸.局部晚期子宫颈癌新辅助化疗价值的评估[J].中华妇产科杂志,2006,41(2):95-98. 被引量:66
  • 4Duenas-Gonzalez A, Lopez-Graniel C, Gonzalez-Enciso A, et al. A phase Ⅱ study of multimodality treatment for locally advanced cervical cancer:neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation[ J ]. Ann Oncol,2003,14 (8) : 1 284. 被引量:1
  • 5Kelling J, Sullivan K, Wilson L, et al. Suppression of centromere dynamics by taxol in living osteosarcoma cells[J]. Cancer Res,2003,63(11) :2 794. 被引量:1
  • 6Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials[ J]. Eur J Cancer, 2003,39(17) :2 470. 被引量:1
  • 7Fattorossi A, Battaglia A, Ferrandina G, et al. Neoadjuvant therapy changes the lymphocyte composition of tumor-draining lymph nodes in cervical carcinoma[J]. Cancer,2004, 100(7):1 418. 被引量:1
  • 8Yamakawa Y, Fujimura M, Hidaka T, et al. Neoadjuvant intraarterial infusion chemotherapy in patients witI1 stage I B2- III B2 cervicl cancer [J]. Gynecol onco1,2000,77 (2) :264. 被引量:1
  • 9WHO. World Health Organization report:comprehensive cervical canc- er control : a guide to essential practice [ R ]. World Health Organiza- tion Web Site ,2006. 被引量:1
  • 10Bae JH, Lee SJ , Lee A, et al. Neoadjuvant lisplatin and etoposide fol- lowed by radical hysterectomy for stage 1B-2B cervical cancer [J]. Avnewl Onco1.2008.111 ( 3 ) :444. 被引量:1

共引文献196

同被引文献70

引证文献6

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部